Banner

In the pipeline: B&L, InSite to develop compound for infections

Article

San Dimas, CA-Bausch & Lomb and InSite Vision will develop a fourth-generation fluoroquinolone that incorporates InSite Vision's drug delivery system, DuraSite.

Related Videos
Related Content

Tackling negotiations for contracts

September 25th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Orbis International partnering with the Alcon Foundation, OMEGA to improve eye care in Zambia

September 25th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Editorial: Reflection uncovers importance of work-life balance

September 25th 2023

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023

Tackling negotiations for contracts

September 25th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Orbis International partnering with the Alcon Foundation, OMEGA to improve eye care in Zambia

September 25th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Editorial: Reflection uncovers importance of work-life balance

September 25th 2023

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023

Tackling negotiations for contracts

September 25th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Orbis International partnering with the Alcon Foundation, OMEGA to improve eye care in Zambia

September 25th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Editorial: Reflection uncovers importance of work-life balance

September 25th 2023

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023
© 2023 MJH Life Sciences

All rights reserved.